720 related articles for article (PubMed ID: 23079770)
1. Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.
Elm JJ;
Mov Disord; 2012 Oct; 27(12):1513-21. PubMed ID: 23079770
[TBL] [Abstract][Full Text] [Related]
2. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.
; Kieburtz K; Tilley BC; Elm JJ; Babcock D; Hauser R; Ross GW; Augustine AH; Augustine EU; Aminoff MJ; Bodis-Wollner IG; Boyd J; Cambi F; Chou K; Christine CW; Cines M; Dahodwala N; Derwent L; Dewey RB; Hawthorne K; Houghton DJ; Kamp C; Leehey M; Lew MF; Liang GS; Luo ST; Mari Z; Morgan JC; Parashos S; Pérez A; Petrovitch H; Rajan S; Reichwein S; Roth JT; Schneider JS; Shannon KM; Simon DK; Simuni T; Singer C; Sudarsky L; Tanner CM; Umeh CC; Williams K; Wills AM
JAMA; 2015 Feb; 313(6):584-93. PubMed ID: 25668262
[TBL] [Abstract][Full Text] [Related]
3. Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
Wills AM; Pérez A; Wang J; Su X; Morgan J; Rajan SS; Leehey MA; Pontone GM; Chou KL; Umeh C; Mari Z; Boyd J;
JAMA Neurol; 2016 Mar; 73(3):321-8. PubMed ID: 26751506
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.
NINDS NET-PD Investigators
Neurology; 2006 Mar; 66(5):664-71. PubMed ID: 16481597
[TBL] [Abstract][Full Text] [Related]
5. Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohort.
Wills AM; Li R; Pérez A; Ren X; Boyd J;
J Neurol; 2017 Aug; 264(8):1746-1753. PubMed ID: 28712000
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Functional Decline in Early Parkinson's Disease: NET-PD LS1 Cohort.
Bega D; Kim S; Zhang Y; Elm J; Schneider J; Hauser R; Fraser A; Simuni T
J Parkinsons Dis; 2015; 5(4):773-82. PubMed ID: 26639661
[TBL] [Abstract][Full Text] [Related]
7. Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.
Parashos SA; Luo S; Biglan KM; Bodis-Wollner I; He B; Liang GS; Ross GW; Tilley BC; Shulman LM;
JAMA Neurol; 2014 Jun; 71(6):710-6. PubMed ID: 24711047
[TBL] [Abstract][Full Text] [Related]
8. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
Fahn S;
J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
[TBL] [Abstract][Full Text] [Related]
9. Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1.
Wills AA; Elm JJ; Ye R; Chou KL; Parashos SA; Hauser RA; Bodis-Wollner I; Hinson VK; Christine CW; Schneider JS;
Parkinsonism Relat Disord; 2016 Dec; 33():127-133. PubMed ID: 27743701
[TBL] [Abstract][Full Text] [Related]
10. No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial.
Umeh CC; Pérez A; Augustine EF; Dhall R; Dewey RB; Mari Z; Simon DK; Wills AM; Christine CW; Schneider JS; Suchowersky O
PLoS One; 2014; 9(12):e112287. PubMed ID: 25486269
[TBL] [Abstract][Full Text] [Related]
11. Communicating with participants during the conduct of multi-center clinical trials.
Augustine EF; Dorsey ER; Hauser RA; Elm JJ; Tilley BC; Kieburtz KK
Clin Trials; 2016 Dec; 13(6):592-596. PubMed ID: 27573636
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study.
Carroll CB; Webb D; Stevens KN; Vickery J; Eyre V; Ball S; Wyse R; Webber M; Foggo A; Zajicek J; Whone A; Creanor S
BMJ Open; 2019 Oct; 9(10):e029740. PubMed ID: 31594876
[TBL] [Abstract][Full Text] [Related]
13. Meta-Analysis of Creatine for Neuroprotection Against Parkinson's Disease.
Attia ; Ahmed H; Gadelkarim M; Morsi M; Awad K; Elnenny M; Ghanem E; El-Jaafary S; Negida A
CNS Neurol Disord Drug Targets; 2017; 16(2):169-175. PubMed ID: 27823574
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.
NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators
Lancet Neurol; 2015 Aug; 14(8):795-803. PubMed ID: 26116315
[TBL] [Abstract][Full Text] [Related]
15. Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.
Leehey M; Luo S; Sharma S; Wills AA; Bainbridge JL; Wong PS; Simon DK; Schneider J; Zhang Y; Pérez A; Dhall R; Christine CW; Singer C; Cambi F; Boyd JT
Neurology; 2017 Oct; 89(17):1789-1794. PubMed ID: 28972194
[TBL] [Abstract][Full Text] [Related]
16. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
[TBL] [Abstract][Full Text] [Related]
17. Isradipine Versus Placebo in Early Parkinson Disease: A Randomized Trial.
Parkinson Study Group STEADY-PD III Investigators
Ann Intern Med; 2020 May; 172(9):591-598. PubMed ID: 32227247
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease.
Jankovic J; Hunter C
Parkinsonism Relat Disord; 2002 Mar; 8(4):271-6. PubMed ID: 12039422
[TBL] [Abstract][Full Text] [Related]
19. Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial.
Cummings J; Isaacson S; Mills R; Williams H; Chi-Burris K; Corbett A; Dhall R; Ballard C
Lancet; 2014 Feb; 383(9916):533-40. PubMed ID: 24183563
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease severity and use of dopaminergic medications.
Fang JY; Pérez A; Christine CW; Leehey M; Aminoff MJ; Boyd JT; Morgan JC; Dhall R; Nicholas AP; Bodis-Wollner I; Zweig RM; Goudreau JL;
Parkinsonism Relat Disord; 2015 Mar; 21(3):297-9. PubMed ID: 25541182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
